arrow
C

Changgui Li

xia men university
H指数:33
被引数:5,143

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The mineralocorticoid receptor and its antagonist finerenone regulate hepatic lipid accumulation via the AMPK/SREBP1/FASN signaling

盐皮质激素受体及其拮抗剂非奈利酮通过AMPK/SREBP1/FASN信号通路调控肝脂质积累

2026-06-090
PRE
Perceptions about asymptomatic hyperuricemia and views about urate-lowering therapy in people with asymptomatic hyperuricemia

无症状高尿酸血症患者的认知及对降尿酸治疗的看法

2025-08-290
OAAI
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double-blind, phase 3 trial in China

dotinurad相较于febuxostat治疗痛风的疗效与安全性:一项在中国开展的随机、多中心、双盲、三期临床试验

2025-05-260
OAAI
The Contribution of Mosaic Chromosomal Alterations to Schizophrenia
2025-01-012
PRE
Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout Cohort
2024-08-281
PRE
Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout

根据肾脏尿酸处理分类的高尿酸血症亚型在痛风患者中表现出不同的表型和遗传特征

2024-03-270
PRE